Media & Announcements > The Literature

The Literature

7-Sep-2023

Molecular Cancer Therapeutics 2023
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 4 Pseudokinase and Resensitizes Enzalutamide-Resistant 5 Q2 Prostate Cancer Cells

30-Jan-2023

Science Advances 2020
Thermostable small-molecule inhibitor of angiogenesis and vascular permeability that suppresses a pERK-FosB/DFosB–VCAM-1 axis

30-Jan-2023

Journal of Inflammation Research 2021
BT2 Suppresses Human Monocytic-Endothelial Cell Adhesion, Bone Erosion and Inflammation

28-Nov-2021

JBC Accelerated Communication
Tribbles 2 pseudokinase confers enzalutamide resistance in prostate cancer by promoting lineage plasticity

3-Nov-2021

Molecules 2021
Human Group IIA Phospholipase A2—Three Decades on from Its Discovery